Hugo Lai is a corporate associate in the Hong Kong office of Wilson Sonsini Goodrich & Rosati. His practice focuses on capital markets, including initial public offerings and other corporate compliance work.
Prior to joining the firm, Hugo worked as the assistant vice president in the IPO Vetting, Listing Division of the Hong Kong Exchanges and Clearing Limited. He previously worked as an associate for two other leading international law firms.
Hugo is a native Cantonese speaker and fluent in English and Mandarin.
Hugo Lai is a corporate associate in the Hong Kong office of Wilson Sonsini Goodrich & Rosati. His practice focuses on capital markets, including initial public offerings and other corporate compliance work.
Prior to joining the firm, Hugo worked as the assistant vice president in the IPO Vetting, Listing Division of the Hong Kong Exchanges and Clearing Limited. He previously worked as an associate for two other leading international law firms.
Hugo is a native Cantonese speaker and fluent in English and Mandarin.
- Postgraduate Certificate in Laws, The University of Hong Kong, 2018
- LL.M., London School of Economics and Political Science, 2017
- LL.B., The University of Hong Kong, 2016
- Hong Kong
- Postgraduate Certificate in Laws, The University of Hong Kong, 2018
- LL.M., London School of Economics and Political Science, 2017
- LL.B., The University of Hong Kong, 2016
- Hong Kong
Representative Matters
IPO Vetting
- Vetted multiple listing applications and pre-IPO enquiries, including applicants under Chapters 8, 18, 18A, 18B, 18C, and 19C of the Main Board Rules and applicants under GEM rules*
IPOs
- Acted as the issuer’s counsel for applicants for pre-IPO enquiries/listing applications, including Nayuki Holding Limited (2150.hk), IntelliCentrics Global Holdings Ltd. (6819.hk), TOT BIOPHARM Company Ltd. (1875.hk), and other listing applicants*
- Acted as the sponsors’ counsel for listing applications, including New Horizon Health Limited (6606.hk) and other applicants*
Corporate Governance and Compliance Work
- Advised listed companies on corporate governance and compliance with the Listing Rules and other laws and regulations, including Bank of Chongqing Co., Ltd (1963.hk), China Mobile Ltd. (941.hk), China Oriental Group Co., Ltd. (581.hk), CSMall Group ltd. (1815.hk), IntelliCentrics Global Holdings Ltd. (6819.hk), Want Want China Holdings Ltd. (151.hk), and others*
*Denotes matters handled prior to joining Wilson Sonsini in 2026
Representative Matters
IPO Vetting
- Vetted multiple listing applications and pre-IPO enquiries, including applicants under Chapters 8, 18, 18A, 18B, 18C, and 19C of the Main Board Rules and applicants under GEM rules*
IPOs
- Acted as the issuer’s counsel for applicants for pre-IPO enquiries/listing applications, including Nayuki Holding Limited (2150.hk), IntelliCentrics Global Holdings Ltd. (6819.hk), TOT BIOPHARM Company Ltd. (1875.hk), and other listing applicants*
- Acted as the sponsors’ counsel for listing applications, including New Horizon Health Limited (6606.hk) and other applicants*
Corporate Governance and Compliance Work
- Advised listed companies on corporate governance and compliance with the Listing Rules and other laws and regulations, including Bank of Chongqing Co., Ltd (1963.hk), China Mobile Ltd. (941.hk), China Oriental Group Co., Ltd. (581.hk), CSMall Group ltd. (1815.hk), IntelliCentrics Global Holdings Ltd. (6819.hk), Want Want China Holdings Ltd. (151.hk), and others*
*Denotes matters handled prior to joining Wilson Sonsini in 2026
- Privacy Policy
- Terms of Use
- Accessibility